ARCHIVES

Advocates Ask Genentech To Release FDA Letter On Avastin For Breast Cancer.

This article is from The Cancer Letter archive.

Vol. 32 No. 34 | September 29, 2006

Download PDF Visit The Full Archive

Related Articles

Molecular target Drug Discovery Grants; Unanimously Approved

July 2, 1999

Talactoferrin Second-Line Therapy Increases Survival In Stage IIIB/IV

October 28, 2011

Rising Costs at NCI Threaten To Overtake Slim Increases In Budget Appropriations

March 28, 2014

NCI to Implement More Transparent Formula For Calculating Cancer Center Support Grants

June 11, 2014

Ronald DePinho Apologizes, Takes Responsibility For “Morale Issues” at MD Anderson

September 27, 2013

FDA Ceases Exclusion Of Women From Early Drug Studies

May 7, 1993